Differing T-cell requirements for recombinant retrovirus vaccines (original) (raw)

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge

Martin Lavin

Nature Medicine, 1998

View PDFchevron_right

Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses

Marc Sitbon

Journal of virology, 1993

View PDFchevron_right

Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors

Wibke Bayer

Retrovirology

View PDFchevron_right

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

Suzanne L Elliott

European Journal of Immunology, 2000

View PDFchevron_right

Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease

Masaaki Miyazawa

International Immunology, 2005

View PDFchevron_right

Activation conditions determine susceptibility of murine primary T‐lymphocytes to retroviral infection

Cuiwen Tan

The Journal of Gene …, 1999

View PDFchevron_right

Retroviral immunology: lessons from a mouse model

Kim Hasenkrug

Immunologic Research, 2009

View PDFchevron_right

Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development

Masaaki Miyazawa

Journal of Immunology, 1995

View PDFchevron_right

Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection

Wibke Bayer

PLOS Pathogens

View PDFchevron_right

Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus)

Mirdad Kazanji

Journal of General Virology, 2006

View PDFchevron_right

Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences

carlos irigoyen

Gene Therapy, 2004

View PDFchevron_right

Clonotypic Composition of the CD4+ T Cell Response to a Vectored Retroviral Antigen Is Determined by Its Speed

Kim Hasenkrug

The Journal of Immunology, 2014

View PDFchevron_right

Identification of a Protective CD4 + T-Cell Epitope in p15 gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity

Masaaki Miyazawa

Journal of Virology, 2004

View PDFchevron_right

Vaccine Targeting of Subdominant CD8+ T Cell Epitopes Increases the Breadth of the T Cell Response upon Viral Challenge, but May Impair Immediate Virus Control

Jan Christensen

Journal of immunology (Baltimore, Md. : 1950), 2016

View PDFchevron_right

Novel Role of CD8+ T Cells and Major Histocompatibility Complex Class I Genes in the Generation of Protective CD4+ Th1 Responses during Retrovirus Infection in Mice

K. Hasenkrug

Journal of Virology, 2002

View PDFchevron_right

Identification of a Protective CD4+ T-Cell Epitope in p15gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity

Masaaki Miyazawa

Journal of Virology, 2004

View PDFchevron_right

Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens

Toos Daemen

Vaccine, 2010

View PDFchevron_right

In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity

Marie Rojas

Journal of Virology, 2000

View PDFchevron_right

Vaccination against δ-Retroviruses: The Bovine Leukemia Virus Paradigm

Karina Trono

Viruses, 2014

View PDFchevron_right

Immune suppression of vaccine-induced CD8+ T-cell responses by gamma retrovirus envelope is mediated by interleukin-10-producing CD4+ T cells

Wibke Bayer

Frontiers in Immunology, 2022

View PDFchevron_right

Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice

Martin Kast

Journal of Virology, 1994

View PDFchevron_right

“Negative Vaccination” by Specific CD4+ T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses

Ahmed Hegazy

PLoS ONE, 2007

View PDFchevron_right

Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model

Wibke Bayer

Retrovirology, 2011

View PDFchevron_right

Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system

Toos Daemen

Antiviral Therapy, 2011

View PDFchevron_right

Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+ T-Cell Responses and Confers Enhanced Protection

Wibke Bayer

Journal of Virology, 2010

View PDFchevron_right

Handling of retroviral antigens by human antigen-presenting cells

Francesca Buffa

Research in Virology, 1996

View PDFchevron_right

Protective Efficacy of Multiepitope Human Leukocyte Antigen???A*0201 Restricted Cytotoxic T-Lymphocyte Peptide Construct Against Challenge With Human T-Cell Lymphotropic Virus Type 1 Tax Recombinant Vaccinia Virus

Pravin Kaumaya

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004

View PDFchevron_right

Protection against Lethal Cytomegalovirus Infection bya Recombinant Vaccine Containing a Single Nonameric T-Cell Epitope

Matthias Reddehase

2000

View PDFchevron_right

Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based Immunization

Wibke Bayer

Journal of virology, 2017

View PDFchevron_right

Retroviral transduction of T-cell receptors in mouse T-cells

Michelle Krogsgaard

Journal of visualized experiments : JoVE, 2010

View PDFchevron_right